source Post navigation Altimmune Announces Positive Results from Week 24 Interim Analysis of Pemvidutide MOMENTUM Phase 2 Obesity Trial and 12-Week Phase 1b Type 2 Diabetes Safety Trial – Yahoo Finance SGLT2i treatment correlates with higher risks among patients with … – Healio